Select hospitals have refused to share data to prove they’re not double-dipping drug discounts, Lilly said. Hospitals, which ...

New York lawmakers won't pass a 340B drug program protection bill this session, disappointing hospitals and health centers ...

Eli Lilly moves to deny 340B discounts to hospitals refusing to submit claims data under its documentation policy, escalating ...

Eli Lilly and Company said Monday evening that it will soon end 340B discount pricing for some of the hospitals that have not ...

Eli Lilly gives hospitals 5 days to submit claims data or lose access to discounted 340B drug pricing, enforcing new transparency rules.

Ed’s stories explore prescription drug pricing, affordability and access, as well issues surrounding patents, litigation and legislation. He is also the author of the morning Pharmalittle newsletter ...

With post-pandemic Medicaid enrollments on the decline and expected to fall further, revenue cycle leaders warn that ...

Three hospitals have sued CVS Health alleging the company redirected $250 million in savings from the 340B program. Mount Sinai Hospital, including St. Luke's-Roosevelt Hospital and Mount Sinai Beth ...

Find the week’s updates on 340B litigation to help you stay in the know on how 340B cases are developing across the country. Each week we comb ...

This appeal concerns Maine's effort to use state law to impose additional obligations on drug manufacturers who participate ...